Sialyl salivary-type amylase associated with ovarian cancer
Clinica Chimica Acta, ISSN: 0009-8981, Vol: 391, Issue: 1, Page: 106-111
2008
- 8Citations
- 14Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations8
- Citation Indexes8
- CrossRef6
- Captures14
- Readers14
- 14
Article Description
There have been many reports describing hyperamylasemia, with a salivary-type amylase phenotype, in patients with malignant tumors and/or multiple myelomas. In contrast, we have discovered and characterized a sialyl salivary-type amylase from multiple myeloma and/or lung cancer cells. This paper reports the first association of sialyl salivary-type amylase with ovarian cancer, discovered and characterized using sera from retrospective studies.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0009898108000594; http://dx.doi.org/10.1016/j.cca.2008.01.025; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=41849116294&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/18294455; https://linkinghub.elsevier.com/retrieve/pii/S0009898108000594; https://dx.doi.org/10.1016/j.cca.2008.01.025
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know